Avulux—the world's only clinically proven lens that blocks the harmful light wavelengths linked to migraine attacks—and Eyenavision partnered to launch Chemistrie Avulux, a new eyeglass clip for people who live with migraines and light sensitivity.
Millions of people are impacted by migraines and experience life disruptions as a result of symptoms like severe headaches, nausea and visual disturbances. This complex genetic neurological disorder is often worsened by light, and the innovative Chemistrie Avulux clips are an on-demand solution that builds on the light filtration properties of Avulux. These eyewear clips block up to 97% of harmful blue, amber and red lightwaves linked to triggering or worsening migraine attacks, and let in soothing green light.
Key Themes Behind This Trend
- Migraine Management Tech
- New innovations like Avulux's eyewear clips offer targeted relief for individuals suffering from light-sensitive migraines, emphasizing personalized healthcare solutions.
- Wearable Health Devices
- Chemistrie Avulux's on-demand eyeglass clips exemplify the increasing integration of health solutions into everyday fashion accessories.
- Blue Light Filtering
- Advanced eyewear like Chemistrie Avulux shows the beneficial impact of filtering harmful light wavelengths to alleviate migraine symptoms.
Where This Applies
- Optical Industry
- The partnership between Avulux and Eyenavision reveals opportunities in developing specialized lenses for health and wellbeing.
- Healthcare Technology
- Innovative products like migraine-soothing eyewear clips demonstrate the fusion of medical research and consumer health tech.
- Consumer Electronics
- The increased demand for blue light filtering solutions underscores the potential for growth in consumer electronics focusing on health benefits.
